US2002114795A1PendingUtilityA1
Composition and process for bone growth and repair
Priority: Dec 22, 2000Filed: Dec 22, 2000Published: Aug 22, 2002
Est. expiryDec 22, 2020(expired)· nominal 20-yr term from priority
A61L 27/22A61P 19/08A61K 38/1875A61L 27/24A61L 27/227A61L 27/12A61P 19/00A61L 27/46A61L 27/3616A61L 27/3608A61L 2430/02
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A composition for the induction of bone growth is disclosed. The composition includes a substrate, bone growth protein, and sources of calcium and phosphate. The composition is acidic which promotes high activity of the bone growth protein. The calcium and phosphate sources can be provided as an acidic calcium phosphate salt. Also disclosed are methods of the making the composition and methods of using it.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A bone growth composition, comprising:
(a) a substrate; (b) bone growth protein; (c) a source of calcium; and, (d) a source of phosphate, wherein said composition has an acidic buffering potential in physiological solution.
2 . A bone growth composition, comprising:
(a) a substrate; (b) bone growth protein; and, (c) a source of calcium, wherein said composition has an acidic buffering potential in physiological solution.
3 . A bone growth composition, comprising:
(a) a substrate; (b) bone growth protein; and, (c) a source of phosphate, wherein said composition has an acidic buffering potential in physiological solution.
4 . A bone growth composition as claimed in claim 1 , wherein the source of calcium is an acidic calcium phosphate salt.
5 . A bone growth composition as claimed in claim 4 , wherein the source of calcium is selected from the group consisting of calcium monophosphate, calcium hydrogen phosphate, and calcium pyrophosphate.
6 . A bone growth composition as claimed in claim 1 , wherein the source of phosphate is a sodium phosphate salt.
7 . A bone growth composition as claimed in claim 1 , wherein the substrate is selected from the group consisting of collagen, fibrin, alginate and mixtures thereof.
8 . A bone growth composition as claimed in claim 1 , wherein the bone growth protein is selected from the group consisting of purified bone growth factors, recombinantly produced bone growth factors and mixtures thereof.
9 . A bone growth composition as claimed in claim 8 wherein the bone growth protein comprises a transforming growth factor β(TGF-β) superfamily protein.
10 . A bone growth composition as claimed in claim 8 wherein the bone growth protein comprises Bone Protein.
11 . A process for producing an implantable bone growth composition, comprising:
(a) producing a dispersion of collagen fibrils containing a solubilized sodium phosphate salt; and (b) adding a calcium chloride salt to the dispersion of collagen fibrils to precipitate a calcium phosphate salt onto the surface of said collagen fibrils to produce an implantable bone growth composition.
12 . The process of claim 11 , wherein said solubilized sodium phosphate salt is calcium hydrogen phosphate dihydrate and wherein said calcium phosphate salt is calcium dichloride dihydrate.
13 . A process for producing an implantable bone growth composition, comprising:
(a) producing a dispersion of collagen fibrils containing a solubilized calcium chloride salt; and, (b) adding a sodium phosphate salt to the dispersion of collagen fibrils to precipitate a calcium phosphate salt onto the surface of said collagen fibrils to produce an implantable bone growth composition.
14 . The process of claim 13 , wherein said solubilized sodium phosphate salt is calcium hydrogen phosphate dihydrate and wherein said calcium phosphate salt is calcium dichloride dihydrate.
15 . A process for the induction of bone formation in a mammal, comprising implanting a bone growth composition in said mammal, wherein said composition comprises,
(a) a substrate; (b) bone growth protein; (c) a source of calcium; and, (d) a source of phosphate, wherein said composition has an acidic buffering potential in physiological solution.
16 . A process as claimed in claim 15 , wherein said source of calcium is an acidic calcium phosphate salt.
17 . A process as claimed in claim 16 , wherein said acidic calcium phosphate salt is selected from the group consisting of calcium monophosphate, calcium hydrogen phosphate, and calcium pyrophosphate.
18 . A process as claimed in claim 15 , wherein said source of phosphate is a sodium phosphate salt.
19 . A process as claimed in claim 15 , wherein said substrate is selected from the group consisting of collagen, fibrin, alginate and mixtures thereof.
20 . A bone growth composition as claimed in claim 15 , wherein the bone growth protein is selected from the group consisting of purified bone growth factors, recombinantly produced bone growth factors and mixtures thereof.
21 . A bone growth composition as claimed in claim 20 wherein the bone growth protein comprises a transforming growth factor β(TGF-β) superfamily protein.
22 . A bone growth composition as claimed in claim 20 wherein the bone growth protein comprises Bone Protein.
23 . A process as claimed in claim 15 , wherein said process is a process selected from the group consisting of hip replacement operation, knee replacement operation, spinal fusion, repair of periodontal defects, treatment of osteoporosis, repair of bone defects and repair of bone fractures.Join the waitlist — get patent alerts
Track US2002114795A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.